NCT03843359 2026-01-08
A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors
GlaxoSmithKline
Phase 1 Active not recruiting
GlaxoSmithKline
University Health Network, Toronto
Mayo Clinic
Amgen Research (Munich) GmbH